Characterization of tungiasis infection and morbidity using thermography in Kenya revealed higher disease burden during COVID-19 school closures.
COVID-19
Child
Kenya
Morbidity
Neglected tropical diseases
Thermography
Tungiasis
Journal
Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645
Informations de publication
Date de publication:
21 Mar 2023
21 Mar 2023
Historique:
received:
08
11
2022
accepted:
09
03
2023
entrez:
21
3
2023
pubmed:
22
3
2023
medline:
23
3
2023
Statut:
epublish
Résumé
Tungiasis is a neglected tropical skin disease caused by the sand flea Tunga penetrans. Female fleas penetrate the skin, particularly at the feet, and cause severe inflammation. This study aimed to characterize disease burden in two highly affected regions in Kenya, to test the use of thermography to detect tungiasis-associated inflammation and to create a new two-level classification of disease severity suitable for mapping, targeting, and monitoring interventions. From February 2020 to April 2021, 3532 pupils age 8-14 years were quasi-randomly selected in 35 public primary schools and examined for tungiasis and associated symptoms. Of the infected pupils, 266 were quasi-randomly selected and their households visited, where an additional 1138 family members were examined. Inflammation was assessed using infra-red thermography. A Clinical score was created combining the number of locations on the feet with acute and chronic symptoms and infra-red hotspots. The overall prevalence of tungiasis among all the school pupils who were randomly selected during survey rounds 1 and 3 was 9.3% [95% confidence interval (CI): 8.4-10.3]. Based on mixed effects logistic models, the odds of infection with tungiasis among school pupils was three times higher in Kwale (coastal Kenya) than in Siaya [western Kenya; adjusted odds ratio (aOR) = 0.36, 95% CI: 0.18-0.74]; three times higher in males than in females (aOR = 3.0, 95% CI: 2.32-3.91) and three times lower among pupils sleeping in a house with a concrete floor (aOR = 0.32, 95% CI: 0.24-0.44). The odds of finding an infected person among the household population during surveys before the COVID-19 pandemic was a third (aOR = 0.32, 95% CI: 0.19-0.53) of that when schools were closed due to COVID-19 restrictions and approximately half (aOR = 0.44, 95% CI: 0.29-0.68) in surveys done after school re-opening (round 3). Infection intensity was positively correlated with inflammation as measured by thermography (Spearman's rho = 0.68, P < 0.001) and with the clinical score (rho = 0.86, P < 0.001). Based on the two-level classification, severe cases were associated with a threefold higher level of pain (OR = 2.99, 95% CI: 2.02-4.43) and itching (OR = 3.31, 95% CI: 2.24-4.89) than mild cases. Thermography was a valuable addition for assessing morbidity and the proposed two-level classification of disease severity clearly separated patients with mild and severe impacts. The burden of tungiasis was considerably higher in households surveyed during COVID-19 restrictions suggesting underlying risks are found in the home environment more than in school.
Sections du résumé
BACKGROUND
BACKGROUND
Tungiasis is a neglected tropical skin disease caused by the sand flea Tunga penetrans. Female fleas penetrate the skin, particularly at the feet, and cause severe inflammation. This study aimed to characterize disease burden in two highly affected regions in Kenya, to test the use of thermography to detect tungiasis-associated inflammation and to create a new two-level classification of disease severity suitable for mapping, targeting, and monitoring interventions.
METHODS
METHODS
From February 2020 to April 2021, 3532 pupils age 8-14 years were quasi-randomly selected in 35 public primary schools and examined for tungiasis and associated symptoms. Of the infected pupils, 266 were quasi-randomly selected and their households visited, where an additional 1138 family members were examined. Inflammation was assessed using infra-red thermography. A Clinical score was created combining the number of locations on the feet with acute and chronic symptoms and infra-red hotspots.
RESULTS
RESULTS
The overall prevalence of tungiasis among all the school pupils who were randomly selected during survey rounds 1 and 3 was 9.3% [95% confidence interval (CI): 8.4-10.3]. Based on mixed effects logistic models, the odds of infection with tungiasis among school pupils was three times higher in Kwale (coastal Kenya) than in Siaya [western Kenya; adjusted odds ratio (aOR) = 0.36, 95% CI: 0.18-0.74]; three times higher in males than in females (aOR = 3.0, 95% CI: 2.32-3.91) and three times lower among pupils sleeping in a house with a concrete floor (aOR = 0.32, 95% CI: 0.24-0.44). The odds of finding an infected person among the household population during surveys before the COVID-19 pandemic was a third (aOR = 0.32, 95% CI: 0.19-0.53) of that when schools were closed due to COVID-19 restrictions and approximately half (aOR = 0.44, 95% CI: 0.29-0.68) in surveys done after school re-opening (round 3). Infection intensity was positively correlated with inflammation as measured by thermography (Spearman's rho = 0.68, P < 0.001) and with the clinical score (rho = 0.86, P < 0.001). Based on the two-level classification, severe cases were associated with a threefold higher level of pain (OR = 2.99, 95% CI: 2.02-4.43) and itching (OR = 3.31, 95% CI: 2.24-4.89) than mild cases.
CONCLUSIONS
CONCLUSIONS
Thermography was a valuable addition for assessing morbidity and the proposed two-level classification of disease severity clearly separated patients with mild and severe impacts. The burden of tungiasis was considerably higher in households surveyed during COVID-19 restrictions suggesting underlying risks are found in the home environment more than in school.
Identifiants
pubmed: 36941724
doi: 10.1186/s40249-023-01080-5
pii: 10.1186/s40249-023-01080-5
pmc: PMC10027580
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
24Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 405027164
Organisme : Deutsche Forschungsgemeinschaft
ID : KR 2245/7-1
Organisme : Wellcome Trust
ID : 213724/Z/18/Z
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
PLoS Negl Trop Dis. 2019 Mar 12;13(3):e0007244
pubmed: 30860992
PLoS Negl Trop Dis. 2018 Jan 8;12(1):e0005939
pubmed: 29309411
Trop Med Health. 2017 Sep 15;45:23
pubmed: 28919835
Rev Inst Med Trop Sao Paulo. 2005 Nov-Dec;47(6):307-13
pubmed: 16553319
Signs (Chic). 2014 Jan;39(2):341-363
pubmed: 25489121
PLoS Negl Trop Dis. 2014 Oct 30;8(10):e3133
pubmed: 25356978
Parasitol Res. 2007 Sep;101 Suppl 2:S233-42
pubmed: 17823833
Trop Med Int Health. 2001 Apr;6(4):267-72
pubmed: 11348517
Trop Med Int Health. 2002 Jul;7(7):559-64
pubmed: 12100437
Acta Trop. 2002 Sep;83(3):255-8
pubmed: 12204399
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008296
pubmed: 32614828
PLoS Negl Trop Dis. 2022 Mar 14;16(3):e0010251
pubmed: 35286319
PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005925
pubmed: 28991909
Trans R Soc Trop Med Hyg. 2006 Apr;100(4):371-80
pubmed: 16297946
PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2426
pubmed: 24069481
PLoS Negl Trop Dis. 2019 May 16;13(5):e0007326
pubmed: 31095558
PLoS Negl Trop Dis. 2016 Oct 11;10(10):e0005056
pubmed: 27727268
Parasitol Res. 2003 Aug;90(6):449-55
pubmed: 12768415
PLoS Negl Trop Dis. 2022 Jun 28;16(6):e0010279
pubmed: 35763498
Int J Dermatol. 2007 May;46(5):475-81
pubmed: 17472674
Emerg Infect Dis. 2003 Aug;9(8):949-55
pubmed: 12967492
Parasitol Res. 2003 Jun;90(2):87-99
pubmed: 12756541
Trop Med Infect Dis. 2020 Jul 24;5(3):
pubmed: 32722011
Am J Trop Med Hyg. 2005 Feb;72(2):145-9
pubmed: 15741550
PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004126
pubmed: 26473360
PLoS Negl Trop Dis. 2007 Dec 05;1(3):e87
pubmed: 18160986
Trans R Soc Trop Med Hyg. 2022 Feb 1;116(2):85-86
pubmed: 34352892
Trop Dis Travel Med Vaccines. 2015 Dec 5;1:13
pubmed: 28883944
BMC Infect Dis. 2018 Sep 10;18(1):456
pubmed: 30200882
PLoS Negl Trop Dis. 2021 May 25;15(5):e0009444
pubmed: 34033646
Parasitol Res. 2007 Jan;100(2):413-21
pubmed: 17058108